CD28-CD8+ T cells do not contain unique clonotypes and are therefore dispensable

被引:19
作者
Weinberger, Birgit [1 ]
Welzl, Kathrin [1 ]
Herndler-Brandstetter, Dietmar [1 ]
Parson, Walther [2 ]
Grubeck-Loebenstein, Beatrix [1 ]
机构
[1] Austrian Acad Sci, Inst Biomed Aging Res, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Inst Legal Med, A-6020 Innsbruck, Austria
关键词
CMV-specific T cell; Elimination; Immunosenescence; T cell receptor; HUMAN CYTOMEGALOVIRUS-INFECTION; IN-VITRO RESTIMULATION; CD28; EXPRESSION; OLD-AGE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; THYMIC OUTPUT; HUMAN VIRUS; CD8(+); MEMORY;
D O I
10.1016/j.imlet.2009.08.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Highly differentiated CD28(-) effector T cells which accumulate in a variety of diseases and also with increasing age contribute to inflammatory processes, limit immunological space and diversity, and are associated with immunological dysfunction and reduced responses to vaccination. Elimination of CD28(-) T cells has been suggested as a measure for immunological rejuvenation but may lead to the loss of important T cell specificities. Using T cells specific for the immunodominant CMV-derived epitope NLVP-MVATV as a model, we show that the same clonotypes are present in CD8(+)CD28(+) naive/early memory and CD8(+)CD28(-) effector T cells. Therefore, CD28(-) cells do not seem to contain clones which are not present in the residual population. The elimination of effector T cells would not lead to the loss of important specificities, as relevant clonotypes could be recruited and propagated from naive or early memory T cell subsets in the case of exposure to pathogen. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 64 条
[1]   CD28-mediated co-stimulation: A quantitative support for TCR signalling [J].
Acuto, O ;
Michel, F .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (12) :939-951
[2]   Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system [J].
Alexander, Tobias ;
Thiel, Andreas ;
Rosen, Oliver ;
Massenkeil, Gero ;
Sattler, Arne ;
Kohler, Siegfried ;
Mei, Henrik ;
Radtke, Hartmut ;
Gromnica-Ihle, Erika ;
Burmester, Gerd-Ruediger ;
Arnold, Renate ;
Radbruch, Andreas ;
Hiepe, Falk .
BLOOD, 2009, 113 (01) :214-223
[3]   Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells [J].
Allez, M ;
Brimnes, J ;
Dotan, I ;
Mayer, L .
GASTROENTEROLOGY, 2002, 123 (05) :1516-1526
[4]   Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons [J].
Almanzar, G ;
Schwaiger, S ;
Jenewein, B ;
Keller, M ;
Herndler-Brandstetter, D ;
Würzner, R ;
Schönitzer, D ;
Grubeck-Loebenstein, B .
JOURNAL OF VIROLOGY, 2005, 79 (06) :3675-3683
[5]   IFN-γ production by CMV-specific CD8+ T cells is high in elderly donors [J].
Almanzar, G ;
Würzner, R ;
Schwaiger, S ;
Jenewein, B ;
Keller, M ;
Girubeck-Loebenstein, B ;
Schönitzer, D .
EXPERIMENTAL GERONTOLOGY, 2004, 39 (05) :863-865
[6]   Accelerated immune senescence and HIV-1 infection [J].
Appay, Victor ;
Almeida, Jorge R. ;
Sauce, Delphine ;
Autran, Brigitte ;
Papagno, Laura .
EXPERIMENTAL GERONTOLOGY, 2007, 42 (05) :432-437
[7]  
AZUMA M, 1993, J IMMUNOL, V150, P1147
[8]   How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes [J].
Blasko, I ;
Stampfer-Kountchev, M ;
Robatscher, P ;
Veerhuis, R ;
Eikelenboom, P ;
Grubeck-Loebenstein, B .
AGING CELL, 2004, 3 (04) :169-176
[9]   Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor γ chain signalling cytokines and type IIFN, and increases susceptibility to activation-induced apoptosis [J].
Borthwick, NJ ;
Lowdell, M ;
Salmon, M ;
Akbar, AN .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (07) :1005-1013
[10]  
CALLAHAN JE, 1993, J IMMUNOL, V151, P6657